REVOLUTIONARY manmade antibodies may help some lymphoma patients substantially cut the risk of a blood cancer relapse while eliminating the need for traditional, damaging chemotherapy, a recent medical trial suggests.
Delivered via an infusion, the medication Polivy — also known as polatuzumab vedotin-piiq uses artificial proteins to carry chemotherapy directly to cancer cells to destroy them while leaving healthy tissue unscathed.
This story is from the April 11, 2022 edition of Globe.
Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 8,500+ magazines and newspapers.
Already a subscriber ? Sign In
This story is from the April 11, 2022 edition of Globe.
Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 8,500+ magazines and newspapers.
Already a subscriber? Sign In
WHY BREAST CANCER COMES BACK!
What every gal needs to know
PET HOARDERS COLLARED!
Dead critters kept in couple's crib
STREISAND'S GOING DEAF!
Why Barbra will never sing again
KILLED BY RAMPAGING ELEPHANT!
American tourist's bucket list holiday ends in tragedy
NASA NAILED UFO COVER-UP
Experts blast explanation for odd images of lunar spacecraft
BALDWIN'S LOOK ARE SHOT TO HELL!
Stress is killing old matinee idol
INSECURE K-CLAN BEACH BUNNIES KICK SAND IN EACH OTHER'S FACES!
Mean momager Kris stirs the pot from 3,000 miles away!
TRAVIS IS FAT & UNHAPPY!
Tay-Tay has her bored beefcake on very strict diet
SICKLY CHER'S YOUNG STUD IS BODY SLAVE
Illnesses taking toll on romance
PARTON OF THE WAYS!
Dolly's family jockeying for slices of her $650M fortune
